Register entry
Corden Pharma International GmbH
- Registered sites
- 4
- Drug products
- 14
- Live patents
- 0
- Countries
- 3
- Base
- Germany
Authorisation
Registered operations
What the FDA has registered these sites to do. This is the regulatory record, not a marketing claim.
Analytical testingActive ingredient (API) manufactureLabellingFinished drug manufacturePackaging
Sites
Facilities
4| Site | Location | Operations | FEI |
|---|---|---|---|
| Corden Pharma Switzerland LLC | LiestalSwitzerland | Analytical testing, Active ingredient (API) manufacture | 3002561809 |
| Corden Pharma International GmbH | Frankfurt am MainGermany | Active ingredient (API) manufacture | 3012722976 |
| Corden Pharma GmbH | PlankstadtGermany | Analytical testing, Labelling, Finished drug manufacture, Packaging | 3007014398 |
| CORDEN PHARMA SPA | CaponagoItaly | Analytical testing, Labelling, Finished drug manufacture, Packaging | 3002880938 |
Catalogue
Marketed products
14Showing 14 of 14.
| Brand | Generic name | Form | Category |
|---|---|---|---|
| - | Bicalutamide | TABLET, FILM COATED | DRUG FOR FURTHER PROCESSING |
| - | Gemcitabine | TABLET | DRUG FOR FURTHER PROCESSING |
| - | Pafolacianine sodium | INJECTION, POWDER, FOR SOLUTION | DRUG FOR FURTHER PROCESSING |
| - | Resmetirom | TABLET | DRUG FOR FURTHER PROCESSING |
| - | Resmetirom | TABLET | DRUG FOR FURTHER PROCESSING |
| - | Resmetirom | TABLET | DRUG FOR FURTHER PROCESSING |
| - | Resmetirom | TABLET | DRUG FOR FURTHER PROCESSING |
| - | Resmetirom | TABLET | DRUG FOR FURTHER PROCESSING |
| - | Resmetirom | TABLET | DRUG FOR FURTHER PROCESSING |
| - | Roflumilast | TABLET | DRUG FOR FURTHER PROCESSING |
| - | Roflumilast | TABLET | DRUG FOR FURTHER PROCESSING |
| - | Urea | TABLET | DRUG FOR FURTHER PROCESSING |
| - | tucatinib | TABLET, FILM COATED | DRUG FOR FURTHER PROCESSING |
| - | tucatinib | TABLET, FILM COATED | DRUG FOR FURTHER PROCESSING |
Provenance
Facility and operations data from the FDA Drug Establishments Current Registration Site. Product data from the openFDA National Drug Code Directory. Patent and exclusivity data from the FDA Orange Book. Shortage data from the FDA drug shortage database. Contact details the FDA publishes for registered establishments are deliberately not reproduced here. This entry is compiled from public records and has not been claimed by the company.